Proteomics International

We’re excited to be at the National Kidney Foundation 𝗦𝗽𝗿𝗶𝗻𝗴 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 this week, surrounded by innovators and clinicians dedicated to advancing kidney care. NKF is a great conference, full of meaningful conversations and fresh insights into the future of nephrology. 📢 Our team is proud to be presenting a poster titled: “𝗣𝗿𝗼𝗺𝗮𝗿𝗸𝗲𝗿®𝗗, 𝗮 𝗻𝗼𝘃𝗲𝗹 𝗶𝗺𝗺𝘂𝗻𝗼𝗮𝘀𝘀𝗮𝘆-𝗯𝗮𝘀𝗲𝗱 𝗯𝗹𝗼𝗼𝗱 𝘁𝗲𝘀𝘁 𝘁𝗼 𝗽𝗿𝗲𝗱𝗶𝗰𝘁 𝗱𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗸𝗶𝗱𝗻𝗲𝘆 𝗱𝗶𝘀𝗲𝗮𝘀𝗲.” This study aimed to develop and validate a next-generation version of the PromarkerD test to provide earlier, more accurate risk prediction for diabetic kidney disease. If you're attending NKF, be sure to check out our poster at 𝗚-𝟒𝟏𝟗, presented by J. Chuck Morrison.

🌟 Spotlight on Research Excellence 🌟 A groundbreaking prognostic test developed through collaboration between The University of Western Australia and Perth-based Proteomics International has been highlighted as the most prominent translational outcome in diabetes research by the National Health and Medical Research Council (NHMRC). In a recent national report evaluating outcomes of NHMRC-funded programs in diabetes from 2000 to 2023, PromarkerD was recognised for its significant advancement in the clinical prediction of diabetic kidney disease. The revolutionary blood test, which can predict kidney function decline up to four years before clinical symptoms appear, was developed using samples and data from the NHMRC-funded landmark Fremantle Diabetes Study. Professor Timothy Davis from the UWA Medical School, a key researcher behind the innovation, said the acknowledgment from NHMRC validated years of collaborative research between UWA's Fremantle Hospital Unit and Proteomics International. See here to learn more about this important research: https://lnkd.in/gvtYcUUr #UWA #UWAMedicalSchool #ResearchExcellence

𝗣𝗲𝗿𝘀𝗶𝘀𝘁𝗲𝗻𝘁 𝗛𝗲𝗮𝗿𝘁𝗯𝘂𝗿𝗻 𝗖𝗮𝗻 𝗦𝗶𝗴𝗻𝗮𝗹 𝗘𝘀𝗼𝗽𝗵𝗮𝗴𝗲𝗮𝗹 𝗖𝗮𝗻𝗰𝗲𝗿 April is 𝗘𝘀𝗼𝗽𝗵𝗮𝗴𝗲𝗮𝗹 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵 in Australia, affecting over 1,600 Australians each year, primarily men. 🔍 𝗪𝗮𝘁𝗰𝗵 𝗳𝗼𝗿 𝘀𝘆𝗺𝗽𝘁𝗼𝗺𝘀:  - Persistent heartburn or acid reflux (GERD)  - Difficulty swallowing  - Unexplained weight loss    💡 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? Frequent heartburn, linked to GERD, can increase esophageal cancer risk. Early detection is vital and can save lives.    At Proteomics International, we are committed to advancing innovative diagnostic solutions to support detection for those at risk of esophageal cancer.    💙 H𝗲𝗹𝗽 𝗿𝗮𝗶𝘀𝗲 𝗮𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀:  • 𝗦𝗵𝗮𝗿𝗲 𝘁𝗵𝗶𝘀 𝗽𝗼𝘀𝘁.  • 𝗘𝗻𝗰𝗼𝘂𝗿𝗮𝗴𝗲 𝗼𝘁𝗵𝗲𝗿𝘀 𝘁𝗼 𝗰𝗼𝗻𝘀𝘂𝗹𝘁 𝗮 𝗱𝗼𝗰𝘁𝗼𝗿 about ongoing symptoms.  • 𝗪𝗲𝗮𝗿 𝗽𝗲𝗿𝗶𝘄𝗶𝗻𝗸𝗹𝗲 𝗯𝗹𝘂𝗲 in support. Together, we can make a difference!    #EsophagealCancerAwareness #CancerAwarenessMonth #CancerCouncilAustralia #Proteomics #PIQ #GERD #Heartburn  

"𝗛𝗶𝗴𝗵-𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀 𝗳𝗼𝗿 𝗺𝗔𝗯𝘀 𝗮𝗻𝗱 𝗢𝘁𝗵𝗲𝗿 𝗕𝗶𝗼𝘀𝗶𝗺𝗶𝗹𝗮𝗿𝘀" As more and more biologics reach patent expiry, the demand for 𝗯𝗶𝗼𝘀𝗶𝗺𝗶𝗹𝗮𝗿 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 is accelerating — especially in the field of cancer immunotherapy. 𝗪𝗶𝘁𝗵 𝗯𝗹𝗼𝗰𝗸𝗯𝘂𝘀𝘁𝗲𝗿 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 𝗹𝗶𝗸𝗲 💉𝗣𝗲𝗺𝗯𝗿𝗼𝗹𝗶𝘇𝘂𝗺𝗮𝗯 (𝗞𝗲𝘆𝘁𝗿𝘂𝗱𝗮®)—𝗮 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗰𝗵𝗲𝗰𝗸𝗽𝗼𝗶𝗻𝘁 𝗶𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿 𝘂𝘀𝗲𝗱 𝗶𝗻 𝗰𝗮𝗻𝗰𝗲𝗿 𝗶𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆—𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗶𝗻𝗴 𝗽𝗮𝘁𝗲𝗻𝘁 𝗲𝘅𝗽𝗶𝗿𝘆, 𝘁𝗵𝗲 𝗿𝗮𝗰𝗲 𝘁𝗼 𝗱𝗲𝘃𝗲𝗹𝗼𝗽 𝗯𝗶𝗼𝘀𝗶𝗺𝗶𝗹𝗮𝗿𝘀 𝗶𝘀 𝗵𝗲𝗮𝘁𝗶𝗻𝗴 𝘂𝗽. At 𝗣𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹, we specialise in advanced analytical services to support biosimilar developers, including: ✔️ Detailed protein structure  ✔️ Peptide Mapping and disulfide bridge analysis ✔️ Robust comparability studies for regulatory approval 🧪 Trust our 𝗜𝗦𝗢 𝟭𝟳𝟬𝟮𝟱-𝗮𝗰𝗰𝗿𝗲𝗱𝗶𝘁𝗲𝗱 lab to deliver high-quality data across your biologic's lifecycle. 📍 Learn more: https://lnkd.in/dtjAveu4 #Biosimilars #Biologics #Immunotherapy #CancerResearch #Pembrolizumab #CheckpointInhibitors #ProteinAnalysis #MassSpectrometry #Proteomics #ProteomicsInternational #Bioanalytics #PatentExpiry #NextGenBiologics

Unfortunately the news is not great. Latest data from the ABS shows 1 million additional Australians now have early markers of chronic kidney disease. That’s 1 in 7 Australian adults. The best way to End Dialysis by 2050 is early detection and prevent progression. We ask all sides of government to support our election ask to get in front if this insideous disease for the first time. Visit www.kidney.org for all the details.. Global Patient Alliance for Kidney Health Kidney Health Australia AstraZeneca Boehringer Ingelheim Australian New Zealand Society of Nephrology (ANZSN) #enddialysisby2050 #kidney #kidney disease Ged Kearney Marielle Smith Mark Butler MP Anne Ruston

🌟𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀 𝗳𝗿𝗼𝗺 𝗣𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹!🌟 We are proud to announce the formation of a 𝗻𝗲𝘄 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗔𝗱𝘃𝗶𝘀𝗼𝗿𝘆 𝗕𝗼𝗮𝗿𝗱 to support the global commercialization of our world-first diagnostic blood test for the detection, and rule-out, of esophageal cancer. This distinguished panel of global experts brings unparalleled experience across Gastroenterology, Esophageal Cancer, and diseases of the Esophagus. Their strategic guidance and clinical insights will play a critical role as we advance precision diagnostics and aim to improve outcomes for those at risk of this serious condition. The Clinical Advisory Board members include: 🔹 Professor Hugh Barr (Gloucestershire Hospitals NHS Trust, UK) 🔹 Professor Jacques Bergman (Amsterdam University Medical Center,     The Netherlands) 🔹 Professor Andrew Chang (University of Michigan, USA) 🔹 Professor Prasad Iyer (Mayo Clinic, USA) 🔹 Dr Daniela Molena (Memorial Sloan Kettering Cancer Center, USA) 🔹 Professor Robert Odze (Tufts University Medical School, USA) 🔹 Professor Krish Ragunath (Royal Perth Hospital & Curtin University,     Australia) With 𝗰𝗵𝗿𝗼𝗻𝗶𝗰 𝗮𝗰𝗶𝗱 𝗿𝗲𝗳𝗹𝘂𝘅, a clinical precursor to esophageal adenocarcinoma, affecting around 20% of the US population, the need for a non-invasive, cancer rule-out tool has never been greater. We welcome our Clinical Advisory Board members on this important journey towards the future of esophageal cancer diagnostics. Together, we look forward to giving peace of mind to millions of people with chronic gastric reflux. #EsophagealCancerAwareness #CancerAwarenessMonth #PIQ https://lnkd.in/gMVbg4sc

𝗝𝗠𝗠 𝗯𝗶𝗼𝘁𝗲𝗰𝗵 𝗳𝗼𝗿𝘂𝗺 𝟐𝟎𝟐𝟓  Proteomics International (ASX:PIQ) is pleased to announce that Managing Director Dr Richard Lipscombe, will also be presenting the Proteomics International story at the JMM Biotech Forum 2025 on 10th April 2025, at 10:30am AEST. To register to attend please use this link - https://lnkd.in/gXxXHUxp To find out more about Proteomics International, visit our website - https://lnkd.in/eeH_eEaQ Jane Morgan #Biotechnology #Precisiondiagnostics #MedTech #PIQ #ASX

📢 Proteomics International is thrilled to share that 𝗣𝗿𝗼𝗺𝗮𝗿𝗸𝗲𝗿®𝗗 is featured on the front cover of the latest issue of Diagnostics MDPI. The study, titled "PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes", shows that 𝗣𝗿𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝗗 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁𝗹𝘆 𝗼𝘂𝘁𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝘀 𝗰𝘂𝗿𝗿𝗲𝗻𝘁 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱-𝗼𝗳-𝗰𝗮𝗿𝗲 𝘁𝗲𝘀𝘁𝘀 in predicting future kidney function decline in people with type 2 diabetes. The paper is part of the Special Issue ‘𝘊𝘶𝘳𝘳𝘦𝘯𝘵 𝘐𝘴𝘴𝘶𝘦𝘴 𝘰𝘯 𝘒𝘪𝘥𝘯𝘦𝘺 𝘋𝘪𝘴𝘦𝘢𝘴𝘦𝘴 𝘋𝘪𝘢𝘨𝘯𝘰𝘴𝘪𝘴 𝘢𝘯𝘥 𝘔𝘢𝘯𝘢𝘨𝘦𝘮𝘦𝘯𝘵 2025’, highlighting the importance of innovation in tackling this global health challenge. A big congratulations to the entire team and our collaborators for this milestone! Check out the issue here: https://lnkd.in/g9vQNR37 #PromarkerD #Proteomics #DKD #Innovation #Biomarkers #PrecisionMedicine #CKD #t2d

🔬 𝗦𝗲𝗮𝗺𝗹𝗲𝘀𝘀 𝗣𝗞 & 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 – 𝗔𝗹𝗹 𝗶𝗻 𝗢𝗻𝗲 𝗟𝗮𝗯! Conducting 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗸𝗶𝗻𝗲𝘁𝗶𝗰 (𝗣𝗞) 𝘀𝘁𝘂𝗱𝗶𝗲𝘀 in a biomarker discovery lab unlocks powerful advantages: ✅ 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝗱 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 – Link PK data with biomarkers for a deeper understanding of drug behavior. ✅ 𝗙𝗮𝘀𝘁𝗲𝗿, 𝗖𝗼𝘀𝘁-𝗘𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝗦𝘁𝘂𝗱𝗶𝗲𝘀 – Streamlined workflows reduce time and expenses. ✅ 𝗦𝘁𝗿𝗼𝗻𝗴𝗲𝗿 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 – Early biomarker identification enhances efficacy and patient selection. ✅ 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗱𝘃𝗮𝗻𝘁𝗮𝗴𝗲 – Robust, combined data supports smoother approvals. 🔹 𝗢𝗻𝗲 𝗟𝗮𝗯. 𝗢𝗻𝗲 𝗣𝗮𝗿𝘁𝗻𝗲𝗿. 𝗦𝗺𝗮𝗿𝘁𝗲𝗿 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁. 📩 Contact 𝗣𝗜𝗟𝗟 (𝗣𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝗶𝗲𝘀 𝗟𝘁𝗱) today! #Pharmacokinetics #BiomarkerDiscovery #DrugDevelopment #ClinicalResearch #Bioanalytics #MassSpectrometry #PKStudies #Biotech #Proteomics #TranslationalResearch #RegulatoryScience #PrecisionMedicine #PharmaInnovation #Biopharma #LabTesting #ClinicalTrials #Biotechnology #PharmaR&D #IntegratedResearch #BiomarkerValidation

🔎 𝗔𝗽𝗿𝗶𝗹 𝗶𝘀 𝗘𝘀𝗼𝗽𝗵𝗮𝗴𝗲𝗮𝗹 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵 𝗶𝗻 𝗔𝘂𝘀𝘁𝗿𝗮𝗹𝗶𝗮 🌟 Esophageal cancer remains one of the 𝗱𝗲𝗮𝗱𝗹𝗶𝗲𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿𝘀, with a 𝗺𝗼𝗿𝘁𝗮𝗹𝗶𝘁𝘆 𝗿𝗮𝘁𝗲 𝗲𝘅𝗰𝗲𝗲𝗱𝗶𝗻𝗴 𝟖𝟎%, primarily due to 𝗹𝗮𝘁𝗲-𝘀𝘁𝗮𝗴𝗲 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻. 𝗞𝗻𝗼𝘄 𝘁𝗵𝗲 𝗙𝗮𝗰𝘁𝘀:  • 𝗠𝗼𝗿𝗲 𝗰𝗼𝗺𝗺𝗼𝗻 in men than women  • 𝗞𝗲𝘆 𝗿𝗶𝘀𝗸 𝗳𝗮𝗰𝘁𝗼𝗿𝘀: Smoking, heavy alcohol use, obesity, and dietary habits  • 𝗦𝘆𝗺𝗽𝘁𝗼𝗺𝘀 𝘁𝗼 𝘄𝗮𝘁𝗰𝗵 𝗳𝗼𝗿: Difficulty swallowing, persistent heartburn (GERD), and unexplained weight loss 𝗘𝗮𝗿𝗹𝘆 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝘀𝗮𝘃𝗲𝘀 𝗹𝗶𝘃𝗲𝘀. At 𝗣𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹, we’re dedicated to advancing 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 to improve outcomes for those affected by esophageal cancer. Together, let’s 𝗿𝗮𝗶𝘀𝗲 𝗮𝘄𝗮𝗿𝗲𝗻𝗲𝘀s, 𝘀𝗵𝗮𝗿𝗲 𝗸𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲, and support those impacted by this disease. #EsophagealCancerAwareness #CancerAwarenessMonth #CancerCouncilAustralia #Proteomics #PIQ #GERD #Heartburn